
Cerebrolysin60 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Cerebrolysin, explained simply
A multicomponent preparation derived from porcine brain tissue that contains neuropeptides and amino acids.
Research area
Neuroprotection and cognitive function
How it works
Its low-molecular-weight components are studied for neurotrophic effects resembling factors involved in neuronal survival.
Why it matters
It has been investigated in neurological settings including stroke and cognitive impairment.
What has been observed
Preclinical neuroprotective signals sit alongside more variable clinical findings, especially in stroke studies.
Effects and points to consider
The cited clinical work concerns specific preparations and routes of administration, which cannot automatically be applied to every vial or method of use.
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 60 mg Cerebrolysin |
|---|---|
| Final volume | 3 mL |
| Concentration | 20 mg/mL |
| One U-100 unit | 200 mcg in 0.01 mL |
Standard / Gradual Approach (3 mL = 20 mg/mL)
| Week | Daily Dose (mg) | Units (per injection) (mL) |
|---|---|---|
| Week 1 | 20 mg (20,000 mcg) | 100 units (1.0 mL) × 1 |
| Week 2 | 24 mg (24,000 mcg) | 60 units (0.6 mL) AM + 60 units (0.6 mL) PM |
| Week 3 | 28 mg (28,000 mcg) | 70 units (0.7 mL) AM + 70 units (0.7 mL) PM |
| Week 4+ | 32 mg (32,000 mcg) | 80 units (0.8 mL) AM + 80 units (0.8 mL) PM |
Supplies needed


Sterile alcohol swabs
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.